Kazumasa Fujitani
7PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 17, 2026
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy for type 4 or large type 3 gastric cancer (OGSG 1402).Ryo Tanaka, Sang-Woong Lee, Kazumasa Fujitani
|Dec 10, 2020
Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.Kazumasa Fujitani, Kohei Shitara, Atsuo Takashima
|Nov 02, 2020
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.Kazumasa Fujitani, Kohei Shitara, Atsuo Takashima
|Jun 24, 2020
Posttherapy topographical nodal status, ypN-site, predicts survival of patients who received neoadjuvant chemotherapy followed by curative surgical resection for non-type 4 locally advanced gastric cancer: supplementary analysis of JCOG1004-A.Kazumasa Fujitani, Kenichi Nakamura, Jyunki Mizusawa
|Nov 01, 2019
Five-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002).Kazumasa Fujitani, Shigeyuki Tamura, Yutaka Kimura
|Jun 29, 2018
Multicentre observational study of quality of life after surgical palliation of malignant gastric outlet obstruction for gastric cancer.K Fujitani, M Ando, K Sakamaki
Pageof 2
